This inventor holds 1 USPTO granted patent. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Azusa Katou: Innovator in Antibiotic Development
Introduction
Azusa Katou is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. Her work focuses on combating infectious diseases caused by Gram-positive bacteria, including MRSA.
Latest Patents
Azusa Katou holds a patent for the antibiotic WAP-8294A. This patent details a method for preparing the antibiotic and its pharmaceutically acceptable salts produced by a strain belonging to the genus Lysobacter. The innovative antibiotic WAP-8294A demonstrates excellent therapeutic effects against infectious diseases caused by Gram-positive bacteria, particularly MRSA. The patent outlines a method that involves cultivating a microorganism capable of producing the antibiotic, recovering it from the culture medium, and formulating an antibacterial composition.
Career Highlights
Katou is currently associated with Wakamoto Pharmaceutical Co., Ltd., where she continues her research and development efforts. Her work has been instrumental in advancing antibiotic therapies and addressing the growing concern of antibiotic resistance.
Collaborations
Throughout her career, Azusa Katou has collaborated with notable colleagues, including Yoshitami Ohashi and Haruhisa Hirata. These collaborations have further enriched her research and contributed to the success of her projects.
Conclusion
Azusa Katou's innovative work in antibiotic development highlights her commitment to improving healthcare outcomes. Her contributions are vital in the ongoing battle against antibiotic-resistant infections.